Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
July 22, 2020

Phosphorus and BioIQ announce partnership for at-home Covid-19 testing kits

By GlobalData Healthcare

According to GlobalData, so far, the US has performed 76 tests per million people. Despite having one of the largest numbers of Covid-19 cases in the world, the US testing rate has been one of the lowest. In order to contain the pandemic, various companies have started to develop at-home Covid-19 testing kits.

BioIQ, a healthcare engagement and clinical adherence technology platform company, and Phosphorus Diagnostic LLC, a medical device company, announced a partnership to provide at-home saliva-based testing kits. The joint solution for an at-home testing kit includes Phosphorus’ at-home Covid-19 saliva test kit, which uses the Oragene•Dx (OGD-510) saliva collection device that enables a fully unsupervised collection, and the BioIQ health technology platform for digital symptom assessment and follow-up care navigation.

In order to receive an at-home saliva testing kit, patients have to complete a medical questionnaire, which will be reviewed by an independent physician in order to determine eligibility. Once approved, the patient will receive the testing kit, and after the laboratory receives the sample, results will be available to consumers within 48 hours, along with the consultation with medical personnel.

The at-home testing approach will enable patients to be tested in the safety of their own homes, greatly eliminating infection exposure. At-home testing solutions will not only provide a better alternative to on-site testing of Covid-19, but greatly increase the number of people who have been tested. Furthermore, if testing results prove to be consistently accurate combined with a significant decrease of exposure risk to Covid-19, at-home testing kits will become an important step towards fighting the pandemic.

Related Companies

Content from our partners
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success

Related Report
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU